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Necrotic Myocardial Cells Release Damage-Associated Molecular
Patterns That Provoke Fibroblast Activation In Vitro and Trigger
Myocardial Inﬂammation and Fibrosis In Vivo
Weili Zhang, MD, PhD; Kory J. Lavine, MD, PhD; Slava Epelman, MD, PhD; Sarah A. Evans, PhD; Carla J. Weinheimer, MS;
Philip M. Barger, MD; Douglas L. Mann, MD
Background-—Tissue injury triggers inﬂammatory responses that promote tissue ﬁbrosis; however, the mechanisms that couple
tissue injury, inﬂammation, and ﬁbroblast activation are not known. Given that dying cells release proinﬂammatory “damage-
associated molecular patterns” (DAMPs), we asked whether proteins released by necrotic myocardial cells (NMCs) were sufﬁcient
to activate ﬁbroblasts in vitro by examining ﬁbroblast activation after stimulation with proteins released by necrotic myocardial
tissue, as well as in vivo by injecting proteins released by necrotic myocardial tissue into the hearts of mice and determining the
extent of myocardial inﬂammation and ﬁbrosis at 72 hours.
Methods and Results-—The freeze–thaw technique was used to induce myocardial necrosis in freshly excised mouse hearts.
Supernatants from NMCs contained multiple DAMPs, including high mobility group box-1 (HMGB1), galectin-3, S100b, S100A8,
S100A9, and interleukin-1a. NMCs provoked a signiﬁcant increase in ﬁbroblast proliferation, a–smooth muscle actin activation,
and collagen 1A1 and 3A1 mRNA expression and signiﬁcantly increased ﬁbroblast motility in a cell-wounding assay in a Toll-like
receptor 4 (TLR4)- and receptor for advanced glycation end products–dependent manner. NMC stimulation resulted in a signiﬁcant
3- to 4-fold activation of Akt and Erk, whereas pretreatment with Akt (A6730) and Erk (U0126) inhibitors decreased NMC-induced
ﬁbroblast proliferation dose-dependently. The effects of NMCs on cell proliferation and collagen gene expression were mimicked by
several recombinant DAMPs, including HMGB1 and galectin-3. Moreover, immunodepletion of HMGB1 in NMC supernatants
abrogated NMC-induced cell proliferation. Finally, injection of NMC supernatants or recombinant HMGB1 into the heart provoked
increased myocardial inﬂammation and ﬁbrosis in wild-type mice but not in TLR4-deﬁcient mice.
Conclusions-—These studies constitute the initial demonstration that DAMPs released by NMCs induce ﬁbroblast activation
in vitro, as well as myocardial inﬂammation and ﬁbrosis in vivo, at least in part, through TLR4-dependent signaling. ( J Am Heart
Assoc. 2015;4:e001993 doi: 10.1161/JAHA.115.001993)
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M yocardial injury that results in the death of cardiacmyocytes initiates a characteristic inﬂammatory
response that has a remarkably consistent time course,
regardless of the speciﬁc cause of cell injury. This inﬂam-
matory response can be broadly divided into 3 phases: an
initial inﬂammatory phase, a proliferative phase, and a
maturation phase.1 During the past several decades, a great
deal has been learned with respect to the identity of the
molecules that are responsible for orchestrating the 3
phases of the inﬂammatory response in the heart.1,2
However, what has been lacking is a clear understanding
of how this response is initiated in the heart after tissue
injury.
Germane to the present discussion, recent studies have
shown that when cells die via accidental necrosis, regulated
necrosis (necroptosis), and/or secondary necrosis (late apop-
tosis), the release of their cytosolic contents into the extracel-
lular space initiates a brisk inﬂammatory response that
phenocopies the inﬂammatory response triggered by patho-
genic bacteria and/or viruses.3,4 Because the inﬂammatory
response that ensues after tissue injury occurs in the
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absence of a known pathogenic infection, it is referred to
as “sterile inﬂammation.” Matzinger proposed the danger
model of immunity5 to explain how the innate and adaptive
immune systems were activated by noninfectious stimuli.
Prior models of the immune system had focused on the
concept that the primary function of the immune system
was to discriminate self from nonself6 through recognition
of molecular motifs on pathogenic bacteria and/or viruses,
which were referred to as pathogen-associated molecular
patterns (PAMPs).4,6 The danger model suggests that
damaged or dying cells release endogenous damage-asso-
ciated molecular patterns (DAMPs), which are capable of
eliciting inﬂammatory responses, analogous to the immune
response that is triggered by PAMPs. Matzinger postulated
that the innate immune system evolved not only to detect
molecules that were nonself (PAMPs) but also to detect a
subset of intracellular molecules (DAMPs), which were
hidden by the plasma membrane (hidden-self) and not
ordinarily found in extracellular ﬂuids in the absence of cell
death, damage, or stress.
Pioneering work by Janeway and colleagues demon-
strated that mammalian cells possess germline-encoded
pattern recognition receptors (PRRs) that are capable of
recognizing conserved molecular motifs shared by PAMPs
and DAMPs.7 The PRRs that have been implicated in sensing
both PAMPs and DAMPs include the canonical PRRs such as
Toll-like receptors (TLRs), nucleotide-binding oligomerization
domain–like receptors and retinoic acid–inducible gene I
receptors, or atypical PRRs such as the receptor for
advanced glycation end products (RAGE).8 Given the afore-
mentioned associations between cell death, inﬂammation,
and tissue repair, we sought to determine whether proteins
released by necrotic myocardial tissue were sufﬁcient to
activate innate immune responses in the heart. Here, we
show for the ﬁrst time that necrotic myocardial cells (NMCs)
release DAMPs that are sufﬁcient to provoke ﬁbroblast
activation in vitro and trigger myocardial inﬂammation and
ﬁbrosis in vivo, at least in part through Toll-like receptor-4
(TLR4) signaling. Remarkably, high mobility group box-1
(HMGB1), a ubiquitous DAMP, is required for ﬁbroblast
activation in vitro and is sufﬁcient to provoke myocardial




Primary cultures of mouse cardiac ﬁbroblasts were prepared
from 12-week-old C57BL/6 background mice as described
previously.9
NIH/3T3 cells
Murine NIH/3T3 ﬁbroblasts was purchased from the Amer-
ican Type Culture Collection and cultured in growth medium,
consisting of DMEM (4.5 g/L glucose) supplemented with
10% fetal bovine serum and 6 mmol/L L-glutamine.
Mouse Lines
The C57BL/6 mice and the TLR4-deﬁcient mice (C57BL/6
background [a gift from Shizuo Akira]10) were maintained in
speciﬁc pathogen-free environment and were fed pellet food
and water ad libitum. All studies were performed with the
approval of the Institutional Animal Care and Use Committee
at Washington University School of Medicine. These investi-
gations conform to the Guide for the Care and Use of
Laboratory Animals, published by the National Institutes of
Health.
Preparation of NMCs
Myocardial cell necrosis was induced by using the freeze–
thaw technique, with a modiﬁcation of the method described
by Scafﬁdi et al.11 Brieﬂy, freshly excised 12-week-old
C57BL/6 mouse hearts (5 to 8 hearts/batch) were rinsed
in cold phosphate-buffered saline (PBS) to remove red blood
cells and then minced into 10 pieces in chilled PBS. To
induce myocardial cell necrosis in normal myocardium, the
tissue slices were suspended in PBS and placed in a conical
tube that was subjected to 1 to 5 freeze–thaw cycles
(10 minutes in methanol on dry ice [<80°] and 3 minutes
in a water bath at 37°C). In preliminary control experiments,
we observed that there was no protein released into the
supernatant from myocardial samples that had not been
subjected to freeze–thaw cycles. After 1 to 5 freeze–thaw
cycles, the NMC suspension was centrifuged at 12 000g for
10 minutes to separate the pellet (unlysed cells and nuclear
fraction) from the cytoplasm (supernatant), and the protein
content of the supernatant was determined by using the BCA
assay (Pierce, Thermo Scientiﬁc). We also observed that 3
freeze–thaw cycles of myocardial tissue yielded near-maximal
protein release into the supernatant in the absence of manual
manipulation of the tissue (Figure 1A). Accordingly, we
standardized the method for inducing myocardial cell necrosis
by using 3 freeze–thaw cycles and pooling the supernatants
from 5 to 8 hearts, which were subsequently aliquoted and
stored at 70°C. The coefﬁcient of variability for the
biological activity of the NMC supernatants, measured in
terms of ﬁbroblast proliferation (see later), was 6.9%
(Figure 1B). To further characterize the NMC supernatants,
2 additional experiments were performed. First, NMC super-
natants were heated to 100°C for 10 minutes to thermally
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denature the proteins in the extracts. Second, the NMC
supernatants were treated with DNase (0.5 lg [Sigma-
Aldrich]) or RNase (0.05 lg [Sigma-Aldrich]), at concentra-
tions that were sufﬁcient to degrade, respectively, 1 lg
plasmid dsDNA or 1 lg total RNA, to remove DNA and/or
RNA from the NMC supernatants.
Preparation of Necrotic Liver Cells
Live cell necrosis was induced by the freeze–thaw technique,
as described earlier using freshly excised livers obtained from
12-week-old C57BL/6 mice.
Western Blot Analysis
To determine whether NMC supernatants contained DAMPS,
Western blot analysis was performed. Brieﬂy, 20-lg cell
extracts were separated electrophoretically, and the mem-
branes were incubated with the following antibodies: HMGB1
(1:1000 [Cell Signaling]), galectin-3 (1:200 [Santa Cruz
Biotechnology, Inc]), S100b (1:50 [Abcam]), S100A8 (2 lg/
mL [R&D systems]), S100A9 (2 lg/mL [R&D systems]),
interleukin (IL)-1a (0.5 lg/mL [R&D systems]), LDH (1:200
Santa Cruz [Biotechnology, Inc]), and GAPDH (1:1000 [Santa
Cruz Biotechnology, Inc]) overnight at 4°C. The membranes
were washed and incubated with the appropriate horseradish
peroxidase–conjugated secondary antibodies for 2 hours.
Immunoreactive bands were visualized on a Kodak Imagine
Station 4000R Pro by using ECL detection reagent.
Fibroblast Proliferation
The proliferation of primary cardiac ﬁbroblasts and NIH/3T3
ﬁbroblast proliferation was determined by measuring bromo-
deoxyuridine (5-bromo-20-deoxyuridine [BrdU]) incorporation
as we have described previously,9 using a commercially
available assay (Colorimetric Cell Proliferation ELISA, Roche).
The ﬁbroblast cell cultures were treated for 48 hours with
PBS, NMC supernatants, or supernatants from necrotic liver
cells (NLCs), heat-denatured NMCs and LMCs, NMCs and
LMCs treated with DNase (0.5 lg/mL) or RNase (0.05 lg/
mL), or 0.1 to 1000 ng/mL recombinant DAMPs (HMGB1
[Sigma-Aldrich], galectin-3 [R&D systems], IL-1a [Cell Sig-
naling], S100b [Sigma-Aldrich], S100A8/A9 [ProSpec-Tany
TechnoGene Ltd]) maintained in serum-free DMEM (Sigma-
Aldrich), followed by the addition of BrdU for an additional
24 hours. In related experiments, the ﬁbroblast cultures
were treated with NMC supernatants for 48 hours in the
presence and absence of increasing concentrations of an
Akt inhibitor, A6730 (0.1 to 0.5 lmol/L [Sigma-Aldrich]), or
increasing concentrations of the ERK inhibitor, U0126 (0.1
to 1.0 lmol/L [Albiochem]), followed by the addition of
BrdU for 24 hours.
Fibroblast a–Smooth Muscle Actin Expression
The a–smooth muscle actin (SMA) expression was deter-
mined by performing ﬂow cytometric analysis of NIH/3T3
ﬁbroblast cultures that had been stimulated for 48 hours
with diluent or NMC supernatants (10 lg/mL), exactly as
described earlier.9 The extent of a-SMA staining in the
ﬁbroblast cultures was expressed as the mean ﬂuorescence
intensity (MFI).
Fibroblast Collagen Gene Expression
Fibroblast cultures were treated with PBS, mouse NMC
supernatants (10 lg/mL), and 0.1 to 1000 ng/mL recombi-
nant DAMPs (HMGB1, galectin-3, IL-1a, S100b, S100A8/A9)
for 48 hours. Total RNA was extracted by using TRIzol reagent
(Invitrogen). Collagen I (collagen 1A1 and 1A2) and collagen III
(collagen 3A1) mRNA levels were quantiﬁed by using real-time
polymerase chain reaction in cardiac ﬁbroblasts, and levels of
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Figure 1. Preparation of cardiac extracts. A, Protein release
into supernatant after 1, 3, or 5 sequential freeze–thaw cycles
(see text for details) of freshly minced mouse hearts. B, BrdU
incorporation in primary cardiac ﬁbroblasts that were treated with
10 lg/mL NMC supernatants obtained from different prepara-
tions of cardiac extracts. All experiments were performed in
triplicate (*P<0.05 compared with diluent). BrdU indicates
bromodeoxyuridine (5-bromo-20-deoxyuridine); NMC, necrotic
myocardial cell; OD, optical density.
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Cell-Wounding Assay
A “scratch tip” (cell-wounding) assay was performed to
determine whether NMC supernatants stimulated ﬁbroblast
migration.12,13 Brieﬂy, NIH/3T3 ﬁbroblasts were seeded in 6-
well plates and cultured in DMEM supplemented with 10%
fetal bovine serum until the ﬁbroblasts grew to conﬂuence.
The ﬁbroblast cultures were then mechanically disrupted by
scratching 2 orthogonal lines (850 to 900 lm in width) in the
center of the monolayer with the use of a sterile 200-lL
pipette tip. After the cultures were rinsed to remove the
disrupted cells, the cell monolayers were refreshed with
serum-free DMEM and then stimulated with diluent, NMC
supernatants (10 lg/mL), denatured NMC supernatants
(10 lg/mL), or basic ﬁbroblast growth factor (bFGF)
(25 ng/mL, Sigma-Aldrich), which was used as a positive
control. To elucidate the mechanism by which NMC super-
natants induced ﬁbroblast migration, the wounded cultures
were pretreated for 30 minutes with a neutralizing concen-
tration of a TLR4 antibody (10 lg/mL, rat monoclonal
MTS510 to TLR4 [GeneTex]), a murine monoclonal anti-RAGE
antibody that did not activate RAGE signaling (500 ng/mL [a
generous gift from Dr Ann Marie Schmidt14]), or isotype (IgG)
control antibodies (10 lg/mL, Sigma-Aldrich) that had no
effect on TLR4- or RAGE-dependent signaling. The cultures
were then treated with NMC or LMC supernatants, heat-
denatured NMC or LMC supernatants, or bFGF for 36 hours.
After 36 hours, the cultures were ﬁxed for 30 minutes in 3.7%
formaldehyde in PBS and then stained with 0.1% toluidine blue
at room temperature for 30 minutes. To standardize the
quantiﬁcation of cell migration in each dish, we enumerated
the number of cells that migrated into a region of interest that
was deﬁned by the area circumscribed within 2 parallel
orthogonal lines (equal to 50% of the scratched area). The
number of cells migrating into a deﬁned region of interest that
was located in the middle of the denuded area (in order to
avoid enumerating cells at the edge of the wound) was
expressed as total cell number per square millimeter. All
measurements were performed by an observer who was
blinded to the treatment protocol.
Akt and Mitogen Activated Protein Kinase
Signaling
NIH/3T3 ﬁbroblasts were stimulated with NMC supernatants
as described above for 0 to 120 minutes, and the cells were
harvested and lysed by using RIPA buffer (Sigma). Cell lysates
(20 lg of protein) were heat-denatured and fractionated on
an Invitrogen NuPAGE 12% gel and then transferred onto pure
nitrocellulose membranes. Blots were probed with either anti-
Akt, anti-Erk (p44/42), anti–c-Jun, or anti-p38 antibodies to
determine the total level of mitogen activated protein kinases
(MAPKs) or with phospho-speciﬁc antibodies to Akt, Erk (p44/
42), c-Jun, or p38 to determine the degree of phosphorylation
(ie, activation) of these MAPKs (all reagents from Cell
Signaling: Akt rabbit monoclonal antibody [mAb] 4691,
phospho-Akt rabbit mAb 4060; p44/42 MAPK (Erk1/2)
antibody 9102, phospho-p44/42 MAPK (Erk1/2) rabbit mAb
4370; c-Jun rabbit mAb 9165, phosphor-c-Jun rabbit mAb
2361; p38 MAPK antibody 9212, phospho-p38 MAPK rabbit
mAb 4511).
Transcriptional Proﬁling
To identify potential molecular pathways that were associated
with NMC-induced ﬁbroblast activation, we performed a
transcriptional proﬁling on NIH-3T3 ﬁbroblast cultures that
were stimulated for 48 hours in serum-free media with either
diluent or NMC supernatants (10 lg/mL). Total RNA was
extracted from 6 separate culture dishes for each group by
using TRIzol reagent (Invitrogen) according to the manufac-
turer’s instructions. RNA was further processed and hybrid-
ized to a Mouse Ref-8 Illumina BeadChip by the Genome
Technology Access Center at Washington University School of
Medicine and scanned with use of the BeadStation system
from Illumina, Inc. Quality standards for hybridization, label-
ing, staining, background signal, and basal level of house-
keeping gene expression for each chip were veriﬁed, as
described.15 Changes in gene expression were analyzed by
using the SAM (Statistical Analysis of Microarray) program
and plotted. Expected differentially expressed genes are
reported on the x axis, whereas observed genes that were
differentially expressed are displayed in the y axis. A false
discovery rate (FDR) <5% was used for the SAM plots.
Functional analysis and pathway analysis were performed by
using Database for Annotation Visualization and Integrated
Discovery (DAVID Bioinformatics Resources 6.7). Lists of
genes that were signiﬁcantly different in the diluent or NMC
supernatant-treated ﬁbroblast cultures were analyzed via
KEGG (Kyoto Encyclopedia of Genes and Genomes) functional
pathway analysis.
Immunodepletion
To identify speciﬁc DAMPs that were responsible for the
effects of NMC supernatants on ﬁbroblast activation, we
performed immunodepletion studies by incubating the NMC
supernatants (10 lg/mL) or supernatants containing puriﬁed
HMGB1 (0.1 lg/mL) with a murine monoclonal HMGB1 2g7
antibody (10 lg/mL, a generous gift from Drs Kevin J. Tracey
and Huan Yang16) or isotype (IgG2b) control antibodies
(10 lg/mL, Sigma-Aldrich) for 30 minutes and then centri-
fuging the samples at 12 000 g for 10 minutes. After
centrifugation, the supernatants were aspirated and used to
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stimulate the ﬁbroblast cultures, exactly as described here
earlier.
Effects of NMCs In Vivo
To determine whether NMC supernatants would provoke
myocardial ﬁbrosis in vivo, we injected NMC supernatants
from syngeneic mice into the left ventricular (LV) apex of wild-
type C57/Bl6 mouse hearts. Brieﬂy, 12-week-old C57BL/6
background mice were anesthetized with Ket/Xyl (100 mg/
10 mg intraperitoneal) and ventilated with use of a Harvard
respirator. A left thoracotomy was performed to visualize the
anterior wall of the LV. NMC supernatants were injected into
the LV apex of the heart by using a 10-lL Hamilton microliter
syringe (Microliter TM 701; Hamilton Company). Care was
taken to ensure that every injection occurred in the same
292-mm space between the left side of the left anterior
descending coronary artery, right side of the septal wall, and
apex of the LV anterior wall. After the injection of the extracts,
the chest was closed, the skin was sutured, and mice were
allowed to recover on a warmer until being returned to their
cages. In the initial studies, 3 experimental groups of mice
were studied: injection of saline (10 lL saline), injection of
denatured NMC supernatants (50 lg protein in 10 lL saline),
and injection of NMC supernatants (50 lg protein in 10 lL
saline). Mice that underwent a thoracotomy and had a visual
inspection of the heart, but no direct myocardial injections,
were used as the appropriate sham-operated controls (n=5 or
6). In additional experiments using the same protocol, we
injected recombinant HMGB1 (200 ng/10 lL, eBioscience)
and denatured HMGB1into wild-type C57/Bl6 mouse hearts
or hearts of TLR4 knock-out mice (C57/Bl6 background). At
72 hours after surgical recovery, the mice were killed, the
hearts were harvested, and parafﬁn sections were made.
Slides were stained with hematoxylin and eosin and picros-
irius red acid, as described previously.9 The degree of
myocardial inﬂammation and myocardial ﬁbrosis were quan-
tiﬁed by computer-assisted densitometric analysis of the
percentage LV apical myocardium with leukocytic inﬁltration
(950) or picrosirius red staining (9100).
Statistical Analysis
All results are expressed as meanSEM values. Data were
assessed with the use of commercially available statistical
software (SigmaStat 3.1; Systat Software Inc). A Student t
test was used to evaluate differences in mean ﬂuorescence
intensity, a-SMA expression, and collagen mRNA expression
between diluent and DAMP-treated ﬁbroblast cultures. One-
way ANOVA was used to analyze mean differences in BrdU
incorporation, cell migration, Akt and MAPK activation,
percent myocardial area with inﬂammation or ﬁbrosis, and
2-way ANOVA was used to analyze differences and cell
migration between diluent and DAMP-treated ﬁbroblast
cultures, as well as cell proliferation in the presence and
absence of A6730 and U0126 and of HGMB1 and anti-HMG1
antibodies. Where appropriate, post-hoc analysis testing was
performed, by using the Holm–Sıdak approach for multiple-
comparison testing. A value of P<0.05 was considered
statistically signiﬁcant.
Results
Characterization of NMC Supernatants
To determine whether NMC supernatants contained DAMPs,
we performed Western blot analysis. As shown in Figure 2A,
NMC supernatants contained multiple DAMPs, including
HGMB1, galectin-3, S100b, S100A8, S100A9, and IL-1a.
Noting that release of DAMPs has been associated with renal
and liver ﬁbrosis,17 we asked whether NMC supernatants
were sufﬁcient to provoke ﬁbroblast activation, which was
deﬁned as (1) increased ﬁbroblast proliferation (BrdU incor-
poration), (2) percentage of ﬁbroblasts with a-SMA staining,
and (3) ﬁbroblast production of extracellular matrix compo-
nents (COL1A1, COL1A2, and COL3A1 mRNA).18
Fibroblast proliferation
Treatment with NMC supernatants for 72 hours provoked a
signiﬁcant (P=0.012) concentration-dependent increase in
cardiac ﬁbroblast proliferation (Figure 2B). The effects of the
NMC supernatants on ﬁbroblast proliferation were abolished
after heat denaturation, whereas treatment of the extracts
with concentrations of RNase and DNase that were sufﬁcient
to degrade RNA (1.0 lg) and DNA (1.0 lg) (Figure 2C) had no
signiﬁcant (P=0.69 and 0.47, respectively) effect on cardiac
extract-induced ﬁbroblast proliferation (Figure 2B). Figure 2D
shows that similar overall results were observed when NIH/
3T3 ﬁbroblasts were treated with NMC supernatants.
Remarkably, supernatants from NLCs provoked a signiﬁcant
dose-dependent increase in NIH/3T3 ﬁbroblast proliferation
(Figure 3), suggesting that the proliferative effects were not
unique to myocardial proteins. Given that the effects of the
NMC supernatants were similar in cardiac ﬁbroblasts and
NIH/3T3 ﬁbroblasts, we performed all subsequent experi-
ments in NIH/3T3 ﬁbroblasts.
a-SMA expression
As shown by the representative ﬂow cytometric analysis
illustrated in Figure 4A and group data shown in Figure 4B,
the mean ﬂuorescence intensity for a-SMA staining was
1.27-fold greater (P=0.003) in ﬁbroblasts treated with NMC
supernatants compared with diluent stimulated ﬁbroblasts.
DOI: 10.1161/JAHA.115.001993 Journal of the American Heart Association 5
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Collagen gene expression
Figure 4C shows that stimulation with NMC supernatants
provoked signiﬁcant increases in collagen 1A1 (P=0.008) and
3A1 (P=0.007) mRNA levels but had no signiﬁcant effect
(P=0.10) on collagen 1A2 mRNA levels. Viewed together, these
observationssuggest thatNMCsupernatantscontainingDAMPs
are sufﬁcient to provoke an activated ﬁbroblast phenotype.
Effect of Recombinant DAMPs on Fibroblast
Activation
Given that these studies demonstrated that NMC superna-
tants contain multiple DAMPs, we next asked whether
individual recombinant DAMPs elicited increased ﬁbroblast
proliferation and increased collagen gene expression.
Fibroblast proliferation
Figure 5 shows that treatment with HMGB1, galectin-3, and
S100A8/A9 signiﬁcantly (P=0.011, 0.03, and 0.001, respec-
tively) increased ﬁbroblast proliferation in a concentration-
dependent manner compared with diluent. However, treatment
with IL-1a or S100b had no signiﬁcant (P=0.34 and 0.43,
respectively) effect on ﬁbroblast proliferation. To determine
whether individual recombinant DAMPs were synergistic with
respect to ﬁbroblast proliferation, we treated ﬁbroblast
cultures with subthreshold concentrations of individual DAMPs
A B
C D
Figure 2. Effect of NMC supernatants on ﬁbroblast proliferation. A, Representative Western blot analyses of NMC supernatants for known
DAMPs, including HGMB1, galectin3, S100b, S100A8, S100A9, and IL-1a. B, Effect of diluent (PBS), NMCs, denatured NMCs, and RNase- and
DNase-treated NMC supernatants on BrdU incorporation in mouse cardiac ﬁbroblasts (n=6 wells/experimental group from 3 independent
experiments). C, Agarose gel of dsDNA (1 lg) and RNA (1 lg) that were treated, respectively, for 30 minutes at 37°C with 0.5 lg/mL DNase and
0.05 lg/mL RNase. D, Effect of diluent (PBS), NMCs, denatured NMCs, and RNase- and DNase-treated NMC supernatants on BrdU incorporation
in NIH/3T3 ﬁbroblast proliferation (n=6 wells/experimental group from 3 independent experiments) (*P<0.05 compared with diluent-treated
controls). BrdU indicates bromodeoxyuridine (5-bromo-20-deoxyuridine); DAMP, damage associated molecular pattern; HMGB1, high mobility
group box-1; IL, interleukin; LDH, lactate dehydrogenase; NMC, necrotic myocardial cell; OD, optical density; PBS, phosphate-buffered saline.
DOI: 10.1161/JAHA.115.001993 Journal of the American Heart Association 6
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that were not sufﬁcient to increase cell proliferation. As shown
in Figure 6, treatment with subthreshold combinations of
DAMPs (1 ng/mL HMGB1, 100 ng/mL galectin-3, and 5 ng/
mL S100A8 and 5 ng/mL S100A9) signiﬁcantly (P=0.009)
increased ﬁbroblast proliferation 1.3-fold compared with
diluent-treated controls. Importantly, the fold-change in ﬁbro-
blast proliferation for 10 lg/mL of NMC supernatants was not
signiﬁcantly (P=0.11) different than the fold-change observed
with subthreshold concentrations of multiple DAMPs. These
data suggest that low concentrations of individual DAMPs have
synergistic effects with respect to ﬁbroblast proliferation.
Collagen gene expression
Treatment with recombinant HMGB1 (1000 ng/mL) and
galectin-3 (1000 ng/mL) signiﬁcantly increased collagen1A1
(P=0.01 and 0.02, respectively) and 3A1 (P=0.02 for both)
mRNA expression but had no signiﬁcant effect (P=0.81 and
0.06, respectively) on collagen 1A2 mRNA levels (Figure 7). In
contrast, IL-1a (1000 ng/mL), and S100A8/A9 (500 ng/mL/
500 ng/mL) and S100b (1000 ng/mL) had no effect on


































Figure 3. Effect of necrotic liver cells (NLCs) on BrdU
incorporation in NIH/3T3 ﬁbroblasts. Fibroblasts cultures were
stimulated for 36 hours with diluent (PBS), NLC supernatants
(10 lg/mL), D-NLC supernatants (10 lg/mL), NLC superna-
tants (10 lg/mL) treated with 0.5 lg/mL DNase, and NLC
supernatants (10 lg/mL) treated with 0.05 lg/mL RNase (n=6
dishes from 3 separate experiments) (*P<0.05 compared with
diluent). BrdU indicates bromodeoxyuridine (5-bromo-20-deoxy-
uridine); D-NLC, denatured necrotic liver cell; OD, optical




Figure 4. Effect of NMCs on the expression of a-SMA and collagen mRNA levels in NIH/3T3 ﬁbroblasts. A, Representative ﬂow
cytometry analysis for a-SMA staining in NIH/3T3 ﬁbroblasts. B, Group data of MFI for a-SMA staining in diluent (PBS)– and NMC
(10 lg/mL)–stimulated cardiac ﬁbroblasts. All experiments were performed in triplicate. C, Collagen 1A1, 1A2, and 3A1 mRNA levels
in ﬁbroblasts stimulated with diluent or NMC supernatants (10 lg/mL). All experiments were performed in triplicate (*P<0.05
compared with diluent). MFI indicates mean ﬂuorescence intensity; NMC, necrotic myocardial cell; PBS, phosphate-buffered saline;
a-SMA, a–smooth muscle actin.
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Effect of NMCs on Fibroblast Migration
Previous studies have shown that DAMPs can induce cell
migration in monocytes, vascular smooth muscle cells, and
ﬁbroblasts through TLR4- and RAGE-dependent signal-
ing.12,13,19–21 To determine whether NMC supernatants
stimulated increased ﬁbroblast migration, we performed a
cell migration assay by using the “scratch tip” (wound-healing)
method.12,13 Figure 8A shows representative phase-contrast
micrographs of conﬂuent ﬁbroblast cell monolayers that were
disrupted by scratching 2 orthogonal lines in the monolayer.
As shown by the representative photographs in Figure 8A,
and summarized in the group data in Figure 8B, both bFGF
(P=0.001) and NMC (P=0.001) supernatants provoked
increased cell migration compared with diluent. Importantly,
the degree of cell migration observed with heat denatured
NMCs was not signiﬁcantly (P=0.21) different from that of
diluent-treated cells. Similar effects were observed with
respect to cell migration when the ﬁbroblasts were stimulated
with supernatants from necrotic liver cells (Figure 9).
To determine whether the effects of NMC supernatants on
ﬁbroblast migration were sensitive to inhibition of TLR4 and/
or the RAGE signaling pathways, we pretreated the ﬁbroblast
cultures with neutralizing TLR4 and RAGE antibodies before
stimulating the ﬁbroblasts with NMC supernatants. The
salient ﬁnding shown in Figure 8C is that cell migration was
signiﬁcantly diminished in the ﬁbroblast cultures treated with
neutralizing TLR4 (P=0.01) and RAGE antibodies (P=0.02)
compared with NMC-treated cultures with identical concen-
trations of isotype (IgG) control antibodies that lacked
speciﬁcity for the TLR4 or RAGE receptors. Importantly,
ﬁbroblast migration was completely abrogated by pretreating
the cultures with a combination of TLR4 and RAGE antibodies











































































Dil     0.1      1       10     100   1000 ng/ml  
Figure 5. Effects of recombinant DAMPs on BrdU incorporation. NIH/3T3 ﬁbroblast cultures were stimulated for 72 hours with 0.1 ng/mL to
1000 ng/mL of (A) HMGB1, (B) galectin-3, (C) IL-1a, (D) S100b, or (E) a combination of equal concentrations of S100A8 (0.05 to 500 ng/mL)
and S100A9 (0.05 to 500 ng/mL). All experiments were performed in triplicate (*P<0.05 compared with diluent). BrdU indicates
bromodeoxyuridine (5-bromo-20-deoxyuridine); DAMP, damage-associated molecular pattern; HMGB1, high mobility group box-1; IL, interleukin;
OD, optical density.
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these ﬁndings with respect to cell migration, we also sought
to determine whether ﬁbroblast proliferation was sensitive to
inhibition of TLR4 and/or RAGE signaling. Figure 8D demon-
strates that treatment with neutralizing antibodies to TLR4
and RAGE signiﬁcantly (P<0.001 and P=0.015, respectively)
attenuated cardiac extract-induced ﬁbroblast cell proliferation
and was completely abolished by treatment with both TLR4
and RAGE antibodies (P=0.60 compared with diluent). In
contrast, isotype (IgG) control antibodies had no signiﬁcant
(P=0.86) effect on cell proliferation. Viewed together, these
data suggest that the NMC supernatants stimulate increased
ﬁbroblast migration and proliferation through TLR4- and
RAGE-dependent signaling pathways. Importantly, liver
extracts also provoked a similar increased fold-change in
ﬁbroblast cell migration (Figure 9), suggesting that the effects
of cardiac proteins on ﬁbroblast proliferation were not unique
to the myocardium.
Mechanism of NMC-Induced Fibroblast
Proliferation
These studies suggested that NMC supernatants activate
ﬁbroblasts through TLR4- and RAGE-dependent signaling
pathways. Recognizing that TLR4 and RAGE receptors both
signal through Akt- and MAPK-dependent signaling path-
ways,12,19 we examined Akt and MAPK activation in
NMC-stimulated ﬁbroblast cultures. As shown in Figure 10A
through 10D, NMC supernatants triggered a signiﬁcant time-
dependent 3- to 4-fold activation of Akt (P=0.001), Erk
(P=0.01), and c-Jun activation (P=0.01) and had no signiﬁcant
(P=0.38) effect on p38 phosphorylation. To determine the role
of Akt and Erk signaling pathways in terms of ﬁbroblast
activation, we pretreated the ﬁbroblast cultures with A6730 to
inhibit Akt signaling, as well as U0126 to inhibit Erk signaling.
The important ﬁnding shown by Figure 10E and 10F, respec-
tively, is that pretreatment with A6730 and U0126 signiﬁ-
cantly (P=0.005 and 0.008, respectively) attenuated cardiac
extract-induced cell proliferation in a dose-dependent manner.
Importantly, the concentrations of A6730 and U0126 that
were used decreased NMC-induced Akt and Erk phosphory-
lation (Figure 11) but did not affect baseline levels of
ﬁbroblast cell proliferation (Figure 10E and 10F).
Transcriptional Proﬁling
The results of the transcriptional proﬁling studies in ﬁbroblast
cultures stimulated with diluent and NMC supernatants are
summarized in Figure 12. The SAM plot shown in Figure 12A
reveals that stimulation of ﬁbroblast cultures for 48 hours
resulted in the differential expression of 996 genes, including
536 genes that were signiﬁcantly upregulated and 460 genes
that were signiﬁcantly downregulated compared with diluent
treatment. An gene ontological analysis of differentially
expressed genes indicated that the genes that were signif-
icantly increased in the ﬁbroblasts stimulated by NMC
supernatants were signiﬁcantly enriched for cellular functions
related to tissue injury and repair, including regulation of cell
death, regulation of growth, cell proliferation, response to
wounding, cell migration/shape and vasculature develop-
ment, and angiogenesis (Figure 12B). The speciﬁc changes in
gene expression for the regulation of cell growth and
response to cell-wounding gene ontological pathways are
summarized in Figure 12C and 12D.
Effects of NMCs In Vivo
To determine whether NMC supernatants were sufﬁcient to
provoke myocardial inﬂammation and/or myocardial ﬁbrosis
in vivo, we injected syngeneic NMC supernatants into the LV
apex of wild-type mouse hearts. Figure 13A displays repre-
sentative histological myocardial sections from hearts sub-
jected to sham operation or hearts that were injected with
saline, NMC supernatants, or denatured NMC supernatants,
whereas Figure 13B summarizes the group data for these
experiments. Both injection of saline and denatured NMC
supernatants provoked a mild inﬂammatory response that


























Figure 6. Synergistic effects of subthreshold concentrations of
recombinant DAMPs on BrdU incorporation in NIH/3T3 ﬁbro-
blasts. Fibroblast cultures were treated for 72 hours with diluent,
(NMC) supernatants (10 lg/mL), and subthreshold concentra-
tions of DAMPs that were not sufﬁcient to provoke increased
BrdU incorporation individually, including HMGB1 (1 ng/mL),
galectin-3 (100 ng/mL), and S100A8/A9 (5+5 ng/mL). All
experiments were performed in triplicate (*P<0.05 compared
with diluent). BrdU indicates bromodeoxyuridine (5-bromo-20-
deoxyuridine); DAMP, damage-associated molecular pattern;
HMGB1, high mobility group box-1; NMC, necrotic myocardial
cell; OD, optical density.
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than that observed with the sham procedure alone. Of note,
the degree of myocardial inﬂammation was not signiﬁcantly
different (P=0.88) between saline injection and injection of
denatured NMC supernatants. However, the remarkable
ﬁnding shown by Figure 13 is that injection of NMC
supernatants provoked a robust inﬂammatory response that
was signiﬁcantly (P=0.005 for both) greater than that
obtained with injection of saline or denatured NMC-injected
hearts. We also examined collagen volume in the same hearts.
The group data in Figure 13D demonstrate that picrosirius red
staining was signiﬁcantly (P=0.004 and 0.005, respectively)
greater in the hearts injected with NMCs, compared with
either saline-injected or denatured NMCs. To determine
whether the observed cardiac extract-induced myocardial
inﬂammation and ﬁbrosis was mediated through TLR4 signal-
ing, as suggested by our in vitro studies, we also injected
NMC supernatants into the LV apex of TLR4-deﬁcient mice
and their respective littermate controls. As shown by the
representative data in Figure 13A and 13C and the group data
illustrated in Figure 13B and 13D, there was no signiﬁcant
difference in the extent of myocardial inﬂammation (P=0.22)
or myocardial ﬁbrosis (P=0.20) in the NMC-injected TLR4
knockout mice, compared with denatured NMC-treated wild-




























































































Dil    HMGB1  Galectin-3  IL-1α S100A8/9   S100β
* *
* *
Figure 7. Effect of recombinant DAMPs on collagen mRNA expression. NIH/3T3 ﬁbroblast cultures were
stimulated for 48 hours with PBS, 1000 ng/mL HMGB1, 1000 ng/mL galectin-3, 1000 ng/mL IL-1a,
500 ng/mL/500 ng/mL of S100A8/A9, and 1000 ng/mL S100b, and collagen 1A1 (A), 1A2 (B), and 3A1
(C) mRNA levels were determined by real-time PCR. All experiments were performed in triplicate (*P<0.05
compared with diluent). DAMP indicates damage-associated molecular pattern; HMGB1, high mobility group
box-1; IL, interleukin; PBS, phosphate-buffered saline; PCR, polymerase chain reaction.
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Mechanism for the Effects of NMC Supernatants
Immunodepletion
To elucidate the mechanism for the effects of the NMC
supernatants on ﬁbroblast proliferation, the NMC superna-
tants were treated with a neutralizing HMGB1 (10 lg/mL)
antibody. As shown in Figure 14A, treatment with an HMGB1
neutralizing antibody abrogated the proliferative effects of
0.1 lg/mL recombinant HMGB1 (P=0.06 compared with
diluent), as well the proliferative effects of NMC (P=0.06
compared with diluent) supernatants (10 lg/mL). Impor-
tantly, neither treatment with an equimolar concentration of
an isotype IgG control antibody nor treatment with a
neutralizing HMGB1 (10 lg/mL) antibody had any effect





Figure 8. Effect of NMC supernatants on ﬁbroblast migration. A, Representative phase-contrast micrographs (950) of scratched cell NIH/
3T3 ﬁbroblast monolayers stimulated for 36 hours with diluent (PBS), NMC supernatants, denatured NMC supernatants, or bFGF (positive
control). The number of cells migrating into the “region of interest” represented by the orthogonal dotted lines illustrated in the PBS-treated
ﬁbroblasts by the lines was used to enumerate the number of migrating cells. B, Results of group data for ﬁbroblasts treated for 36 hours
with PBS, NMC supernatants (10 lg/mL), denatured NMC supernatants (10 lg/mL), and bFGF (25 ng/mL). C, Results of group data for
ﬁbroblasts treated with diluent or NMC supernatants (10 lg/mL), in the presence of IgG, TLR4 antibody (Ab), RAGE Ab, and TLR4 Ab+RAGE
Ab (n=9 dishes for each experimental group from 3 independent experiments). D, Group data for BrdU incorporation in NIH/3T3 ﬁbroblasts
stimulated with diluent or 10 lg/mL NMC supernatants for 72 hours in the presence and absence of IgG, TLR4 Ab, RAGE, and TLR4
Ab+RAGE Ab (n=6 for each group from 3 independent experiments) (*P<0.05 compared with diluent). bFGF indicates basic ﬁbroblast growth
factor; BrdU, bromodeoxyuridine (5-bromo-20-deoxyuridine); NMC, necrotic myocardial cell; PBS, phosphate-buffered saline; RAGE, receptor
for advance glycation end products; TLR4, Toll-like receptor-4.
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Effect of HMGB1 in vivo
To determine whether HMGB1 was sufﬁcient to provoke
myocardial inﬂammation and ﬁbrosis in vivo, we injected
recombinant HMGB1 into the LV apex of wild-type C57/Bl6
and TLR4-deﬁcient mouse hearts and examined myocardial
inﬂammation and myocardial ﬁbrosis at 72 hours. Figure 14B
depicts representative histological myocardial sections from
hearts that were injected with denatured HMGB1 and
recombinant HMGB1; group data are summarized in Fig-
ure 14C. Injection of recombinant HMGB1in wild-type hearts
provoked a robust inﬂammatory response that was signiﬁ-
cantly greater than that observed with denatured HMGB1
(P=0.009). Remarkably, the extent of myocardial inﬂammation
in HMGB1-injected TLR4/ mouse hearts was not signiﬁ-
cantly different (P=0.52) than that observed in wild-type
mouse hearts that were injected with denatured HMGB1. We
also examined collagen volume in the same hearts. As shown
by the representative images in Figure 14D and the group
data in Figure 14E, the extent of picrosirius red staining was
signiﬁcantly greater (P=0.005) in the wild-type mouse hearts
that were injected with HMGB1 compared with wild-type
hearts injected with denatured HMGB1. However, the effects
of HMGB1 on myocardial ﬁbrosis were not signiﬁcantly
different (P=0.54) in TLR4/ mouse hearts, compared with
wild-type mouse hearts injected with denatured HMGB1
Viewed together, the in vitro and in vivo studies suggest that
HMGB1 is an essential mediator of NMC-induced myocardial
inﬂammation and myocardial ﬁbrosis.
Discussion
The ability of the myocardium to successfully compensate for
and adapt to environmental stress ultimately determines
whether the heart will decompensate and fail or whether it will
instead maintain preserved function. Despite the importance
of the myocardial response to environmental stress, very little
is known with respect to the basic mechanisms that are
responsible for initiating stress responses in the heart. Here,
we show for the ﬁrst time that proteins released by NMCs are
sufﬁcient to initiate a repertoire of repair mechanisms in
ﬁbroblasts through activation of TLR4, a canonical innate
immune PRR. Three distinct but mutually complementary
scientiﬁc lines of evidence support this conclusion. First,
Western blot analysis of supernatants from NMCs revealed
the presence of several classic DAMPs, including HGMB1,
galectin-3, S100b, S100A8, S100A9, and IL-1a (Figure 2A).
Treatment of ﬁbroblasts with supernatants from NMCs
increased ﬁbroblast proliferation (Figure 2B and 2D), ﬁbro-
blast a-SMA activation (Figure 4A and 4B), ﬁbroblast expres-
sion levels of collagen 1A1 and collagen 3A1 (Figure 4C), and
ﬁbroblast migration (Figure 8B). The effects of NMC super-
natants on ﬁbroblast proliferation were sensitive to heat
denaturation but were unaffected by treatment with DNase or
RNase, suggesting that the stimulatory molecules present in
the NMC supernatants were proteins and not nucleic acids. In
a cell-wounding assay, NMC supernatants induced increased
ﬁbroblast migration into the denuded area, which could be
partially inhibited by using a TLR4 or RAGE antibody and
completely inhibited by simultaneous treatment with TLR4
and RAGE antibodies or by heat denaturing the NMC
supernatants (Figure 8B and 8C). Noting that both Akt and
MAPKs were downstream from TLR- and RAGE-dependent
signaling, we measured Akt and MAPK activity levels in diluent
and NMC-treated ﬁbroblast cultures. NMC supernatants
increased Akt and Erk phosphorylation in cultured ﬁbroblasts
in a time-dependent manner, whereas inhibition of Akt and
A
B
Figure 9. Effects of necrotic liver cells on NIH/3T3 ﬁbroblast
cell migration. A, Representative phase-contrast micrographs
(950) of scratched cell monolayers stimulated for 36 hours with
diluent (PBS), NLCs, D-NLCs, or bFGF (positive control). B, Results
of group data for ﬁbroblasts treated for 36 hours with PBS (NLCs;
10 lg/mL), D-NLCs (10 lg/mL), and bFGF (25 ng/mL) (*P<0.05
compared with PBS). bFGF indicates basic ﬁbroblast growth
factor; D-NLC, denatured necrotic liver cell; NLC, necrotic liver
cell; PBS, phosphate-buffered saline.
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Erk signaling with speciﬁc inhibitors (A6730 and U0126,
respectively) abolished ﬁbroblast proliferation in a concentra-
tion manner (Figure 10). Remarkably, similar responses in
terms of ﬁbroblast proliferation and motility were observed
with supernatants obtained from NLCs (Figures 3 and 9),
suggesting that the biologically active properties of necrotic
cells were not unique to cell types residing in the heart.




Figure 10. Effect of NMCs on MAPK and signaling in ﬁbroblasts. NIH/3T3 ﬁbroblast cultures were
stimulated with NMC (10 lg/mL) supernatants for the times indicated to determine Akt (A), ERK (p44/
42) (B), c-Jun (C), and p38 (D) activity. Representative Western blots for phospho- Akt, ERK, c-Jun, and p-
38 and total-Akt, ERK, c-Jun, and p-38 are illustrated in the upper panels and group data (expressed as the
ratio of the intensity of the bands corresponding to phosphorylated/total protein) are shown in the lower
panels. All experiments were performed in triplicate (*P<0.05 compared with baseline [0 minutes]). E,
Effect of pretreatment (30 min) with 0.1, 0.25, and 0.5 lmol/L A6730 (Akt inhibitor) on NMC-induced
BrdU incorporation in ﬁbroblasts. F, Effect of pretreatment (30 min) with 0.1, 0.5, and 1.0 lmol/L U0126
(ERK inhibitor) on NMC-induced BrdU incorporation in ﬁbroblasts (n=6 dishes for each experimental group
taken from 3 independent experiments) (*P<0.05 compared with diluent). All experiments were
performed in triplicate. BrdU indicates bromodeoxyuridine (5-bromo-20-deoxyuridine); DAMP, damage-
associated molecular pattern; MAPK, mitogen activated protein kinase; NMC, necrotic myocardial cell;
OD, optical density.
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proliferation were mimicked, in a concentration-dependent
manner, by several puriﬁed recombinant DAMPs that were
immunodetectable in the NMC supernatants, including
HMGB1, galectin-3, and S100A8/S100A9 (Figure 5), whereas
only HMGB1 and galectin-3 increased collagen 1A1 and
collagen 3A1 gene expression (Figure 7). Treatment of
ﬁbroblasts with multiple recombinant DAMPs that were
biologically inactive at lower concentrations increased ﬁbro-
blast proliferation to the same extent as did NMC superna-
tants (Figure 6), suggesting that low concentrations of DAMPs
can act synergistically to induce ﬁbroblast proliferation. Third,
injection of NMC supernatants induced inﬂammation and
myocardial ﬁbrosis in vivo (Figure 13). Importantly, the extent
of inﬂammation and myocardial ﬁbrosis after the injection of
thermally denatured NMCs was not different than that
observed with needle injury alone (Figure 13). Consistent
with our in vitro observations, the effects of NMC superna-
tants on myocardial inﬂammation and myocardial ﬁbrosis
were absent in TLR4-deﬁcient mice (Figure 13). Although
these studies were not intended to identify the biological
effects of the entire portfolio of DAMPs released by NMCs,
under the simple well-deﬁned experimental conditions used in
this study, we show that HMGB1 is necessary and sufﬁcient
for ﬁbroblast activation in vivo (Figure 14A and 14B) as well
as in vitro (Figures 5 and 7). Further, injection of HMBG1 into
wild-type hearts provoked myocardial inﬂammation and
ﬁbrosis in vivo, whereas the proinﬂammatory effects of
HMGB1 in vivo were abrogated by heat denaturation and were
not detectable in the hearts of TLR4-deﬁcient mice (Fig-
ure 14). Viewed together, these data constitute the initial
demonstration that proteins released by NMCs are sufﬁcient
to induce ﬁbroblast activation, myocardial inﬂammation, and
myocardial ﬁbrosis, through activation of classic innate
immune signaling pathways.
Tissue Injury and DAMPs
The biological activity of DAMPs is exceedingly complex and
depends on a variety of factors, including the overall extent of
tissue injury, the type of cell death (necrosis versus apopto-
sis), and the type of cells dying (epithelial versus mesenchy-
mal). DAMPs can be subdivided into 3 broad categories:
(1) intracellular molecules released by dying cells (S100
proteins, HMGB1, IL-1a, galectin-3, heat shock protein [HSP]
A
B
Figure 11. Effect of A6730 on Akt phosphorylation and U0126 on Erk activity. A, Representative Western
blot of phospho-Akt and total Akt levels in NIH/3T3 cells (see text for details). Fibroblast cultures were
pretreated (30 minutes) with 0.1, 0.25, and 0.5 lmol/L A6730 or diluent and then stimulated for
30 minutes with necrotic myocardial cell (NMC) supernatants (10 lg/mL). B, Representative Western blot
of phospho-Erk and total Erk levels in NIH/3T3 cells pretreated (30 minutes) with 0.1, 0.5, and 1.0 lmol/L
U0126 or diluent (same volume of DMSO) and then stimulated for 30 minutes with NMC supernatants
(10 lg/mL). All experiments were performed in triplicate.
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Figure 12. Transcriptional proﬁling in NMC-stimulated ﬁbroblasts. A, SAM plot of changes in
gene expression in NIH/3T3 ﬁbroblasts stimulated with 10 lg/mL NMC supernatants
compared with diluent-treated controls (n=4 separate cultures/group). Genes that were
signiﬁcantly increased are denoted by red circles; genes that were signiﬁcantly decreased are
denoted by green circles. An FDR <5% was used for the SAM plots. B, GO analysis of functional
pathways that were signiﬁcantly different in the NMC-stimulated ﬁbroblast cultures compared
with diluent. C and D, GO analysis of signiﬁcant changes in gene expression in NMC supernatant
(10 lg/mL) stimulated NIH/3T3 ﬁbroblasts (relative to diluent). C, Signiﬁcant changes in gene
expression (fold-change) in the cell growth pathway (GO:0040008). D, Signiﬁcant changes in
gene expression (fold-change) in the response to wounding pathway (GO:0009611) (n=4 sam-
ples/group). FDR indicates false discovery rate; GO, gene ontology; NMC, necrotic myocardial
cell; SAM, Statistical Analysis of Microarray.
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60, HSP 70, HSP 7222) and/or molecules that are expressed
on the cell surface membranes of stressed of dying cells (eg,
phosphatidylserine), (2) leaderless proteins secreted by
professional immune cells, also referred to as “alarmins”
(eg, HMGB1, IL-1b, galectin-3, uric acid), and (3) components
of the extracellular matrix (hyaluronan, heparan sulfate,
ﬁbronectin, and degraded matrix constituents). The precise
biochemical moieties that distinguish whether an intracellular
protein is immunogenic or nonimmunogenic are unclear;
however, it has been proposed that many known DAMPs,
such as the chaperones belonging to the HSP family, contain
hydrophobic regions that are ordinarily hidden in healthy living
cells and become immunogenic when released into the
extracellular space.23 Furthermore, studies have shown the
proinﬂammatory properties of DAMPs such as HMGB1 and
S100A8/S100A9 are highly sensitive to the redox microen-
vironment in the extracellular space. The extracellular milieu
in healthy tissues is oxidizing, which leads to the denaturation
and inactivation of DAMPs that are released into the
extracellular space. In contrast, the release of oxidoreducta-
ses and nonthiol proteins in injured tissue modiﬁes the
extracellular redox state to a reducing environment, which can
increase the proinﬂammatory properties of DAMPs.24,25 For
example, the S-thiolation status of cysteine residues 23, 45,
A B
C D
Figure 13. Effect of NMC supernatants on myocardial inﬂammation and myocardial ﬁbrosis. A, Representative histological myocardial
sections of myocardial inﬂammation from WT and TLR4-deﬁcient (TLR4/) mice that were sham-operated or injected with saline, D-NMC
supernatants, or NMC supernatants (950 magniﬁcation). B, Group data for myocardial inﬂammation (expressed as percentage of myocardial
area) for WT and TLR4-deﬁcient mice that were sham-operated mice or injected with saline, D-NMC supernatants, or NMC supernatants (n=5 or
6 hearts/group). C, Representative picrosirius red staining of myocardial sections (9100 magniﬁcation) from WT or TLR4-deﬁcient mice. D,
Group data for picrosirius red staining (expressed as percentage of myocardial area) for WT and TLR4-deﬁcient mice that were sham-operated
mice or injected with saline, D-NMC supernatants, or NMC supernatants (n=5 or 6 hearts/group) (*P<0.05 compared with sham operated
controls). D-NMC indicates denatured necrotic myocardial cell; NMC, necrotic myocardial cell; TLR4, Toll-like receptor-4; WT, wild-type.
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and 106 on HMGB1 determines whether this chromatin
binding protein engages TLRs and acts as a proinﬂammatory
cytokine or whether it is biologically inert when released into
the extracellular space.25 Additional complexity of DAMP
signaling is conferred by the formation of heterocomplexes
with other immune coactivators such as C-X-Cmotif chemokine






Figure 14. Effects of HMGB1 in vitro and in vivo. A, BrdU incorporation in NIH/3T3 ﬁbroblasts stimulated with NMC (10 lg/mL) supernatants
or recombinant HMGB1, in the presence and absence of IgG2b or an HMGB1 antibody (n=4 to 6 dishes from 3 separate experiments) (*P<0.05
compared with IgG2b control antibody alone). B, Representative myocardial sections (950 magniﬁcation) of myocardial inﬂammation from WT
and TLR4-deﬁcient (TLR4/) mice that were injected with 200 ng/10 lL HMGB1 or 200 ng/10 lL denatured HMGB1. C, Group data for
myocardial inﬂammation (expressed as percentage of myocardial area) for WT and TLR4-deﬁcient mice injected with 200 ng/10 lL HMGB1 or
200 ng/10 lL denatured HMGB1. D, Representative picrosirius red staining of myocardial sections (9100 magniﬁcation) from WT and TLR4-
deﬁcient mice that were injected with 200 ng/10 lL HMGB1 or 200 ng/10 lL denatured HMGB1 (9100 magniﬁcation). E, Group data for
picrosirius red staining (expressed as percentage of myocardial area) in WT and TLR4-deﬁcient mice that were injected with 200 ng/10 lL
HMGB1 or 200 ng/10 lL denatured HMGB1 (n=5 or 6 hearts/group) (*P<0.05 compared with WT mice treated with denatured HMGB1). BrdU
indicates bromodeoxyuridine (5-bromo-20-deoxyuridine); HMGB1, high mobility group box-1; KO, knock-out; NMC, necrotic myocardial cell; TLR4,
Toll-like receptor-4; WT, wild-type.
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While these comments have focused on the proinﬂamma-
tory effects of DAMPs, it bears emphasis that DAMP-induced
inﬂammation is essential to restore tissue homeostasis by
activating tissue repair mechanisms in vivo. DAMPs activate
macrophages, dendritic cells, and endogenous precursor stem
cells that are required for initiating tissue repair.8,27,28 DAMPs
have been shown to induce the proliferation of smooth
muscle cells and ﬁbroblasts29 and to stimulate angiogenesis30
and skeletal and cardiac myogenesis,27,30 as well as to
promote regeneration of renal tubule cells and liver cells.31,32
These reports are consistent with the observations in the
present study, wherein we demonstrate that cardiac DAMPs
are sufﬁcient to increase ﬁbroblast proliferation and mobility,
increase collagen synthesis, and activate a repertoire of gene
ontologies that are involved in the response to wounding and
angiogenesis (Figure 12). We further show that HMGB1, a
nonhistone nuclear protein that has been referred to as the
“master regulator of innate immunity,”28 has a nonredundant
role with respect to ﬁbroblast activation in vitro. Relevant to
the present discussion, HMGB1 is capable of eliciting
pleiotropic effects that depend on its cellular location,
context, and posttranslational modiﬁcation.33 In response to
myocardial injury, HMGB1 translocates from the nucleus to
the cytoplasm in cardiac myocytes and can be released into
the extracellular space through nonclassic secretory mecha-
nisms.34,35 The pleiotropic effects of HMGB1 are in part
related to the plasticity of HMGB1–receptor interactions,
when HMGB1 forms complexes with selected ligands (eg, IL-
1a/b), signaling proteins (eg, CD24 and Siglec-10), and/or
DNA, RNA, and histone proteins.33 Not surprisingly, both
beneﬁcial and deleterious roles have been proposed for
HMGB1 in different models of cardiac injury, which likely
reﬂects the complex and context-dependent biology of
HMGB1.2,22 Because the NIH-3T3 cells used herein were
relatively less sensitive to the effects of DAMPs than primary
cardiac ﬁbroblasts, we cannot exclude the possibility that the
effects of DAMPs on ﬁbroblast activation and/or gene
expression may have been more robust than we observed.
Conclusions
The results of the present study provide an important and
previously undeﬁned mechanistic link between necrotic cell
death, activation of innate immune signaling, and the onset of
tissue repair in the heart. Although the release of DAMPs by
NMCs is likely essential for beneﬁcial healing responses in the
heart, sustained DAMP signaling may also lead to excessive
inﬂammation and adverse LV remodeling because of sus-
tained DAMP-induced inﬂammation and/or enhanced B- and
T-cell responses that arise secondary to processing of DAMPs
by mononuclear phagocytes residing in and/or that are
recruited to the myocardium after tissue injury.36,37 Thus, the
relative contribution of DAMP-mediated signaling to adaptive
and maladaptive responses in the heart will likely be both time
and context dependent. These studies raise the intriguing
possibility that it may be possible to identify candidate DAMPs
that can be exploited as therapeutic targets. As one example,
HMGB1-speciﬁc antagonists have been shown to be effective
in a variety of different animal disease models, including
arthritis, stroke, sepsis, and organ transplantation.33 More-
over, certain motifs residing in DAMPs may be used
therapeutically to exploit regenerative cues for resident
cardiac progenitor cells and/or inﬁltrating cells. For example,
necrotic cell debris enhances the ability of a collagen-based
extracellular matrix to stimulate myogenesis in the mdx
mouse model of Duchenne muscular dystrophy.38 Finally,
although speculative, it is possible that the release of DAMPs
by injected cardiac stem cells may explain, at least in part, the
paradox between the lack of engraftment of these cells and
their observed “paracrine” effects on tissue repair and
angiogenesis.39 Accordingly, further elucidation of the spatial
and temporal role of DAMPs with respect to activating innate
and adaptive immune responses in the heart should provide
important insights into the role of the immune system in
mediating adaptive and maladaptive cardiac remodeling.
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